Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

DuPont designs potent and selective factor Xa inhibitors with excellent PK profile

Sep. 7, 2000

Factor Xa inhibitors with anticoagulant and antithrombotic effects identified at Lilly

Sep. 6, 2000

New series of factor Xa inhibitors claimed by Aventis

Sep. 1, 2000

New series of factor Xa inhibitors reported by German lab

Aug. 31, 2000

Roxifiban inhibits platelet aggregation dose-dependently in CAD patients

Aug. 30, 2000

Safety and efficacy data reported on AstraZeneca's P2T receptor antagonist in PTCA

Aug. 30, 2000

Novel factor Xa inhibitors under development for thromboembolic disorders

Aug. 24, 2000

GlycoDesign and Leo Denmark form joint venture to develop cardiovascular drugs

Aug. 24, 2000

Newly issued patents cover related series of novel amides

Aug. 23, 2000

Novel thrombin inhibitors under study at LG Chemical

Aug. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...